NO984414L - Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse - Google Patents

Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse

Info

Publication number: NO984414L
Authority: NO; Norway
Prior art keywords: new; preparation; pharmaceutical preparations; preparations containing; ring heterocycles
Prior art date: 1997-09-23

Application number

NO984414A

Other languages

English (en)

Norwegian (no)

Other versions

NO984414D0 (no

Inventor

Volkmar Wehner

Hans Ulrich Stilz

Wolfgang Schmidt

Dirk Seiffge

Original Assignee

Hoechst Marion Roussel De Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-23

Filing date

1998-09-22

Publication date

1999-03-24

1998-09-22 Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh

1998-09-22 Publication of NO984414D0 publication Critical patent/NO984414D0/no

1999-03-24 Publication of NO984414L publication Critical patent/NO984414L/no

Links

125000000623 heterocyclic group Chemical group 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Cardiology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Oncology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)

NO984414A 1997-09-23 1998-09-22 Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse NO984414L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19741873A DE19741873A1 (de)	1997-09-23	1997-09-23	Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Publications (2)

Publication Number	Publication Date
NO984414D0 NO984414D0 (no)	1998-09-22
NO984414L true NO984414L (no)	1999-03-24

Family

ID=7843291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO984414A NO984414L (no)	1997-09-23	1998-09-22	Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse

Country Status (24)

Country	Link
US (1)	US6034238A (fr)
EP (1)	EP0905139B1 (fr)
JP (1)	JP4603104B2 (fr)
KR (1)	KR19990030046A (fr)
CN (1)	CN1216767A (fr)
AT (1)	ATE421524T1 (fr)
AU (1)	AU748579B2 (fr)
BR (1)	BR9803969A (fr)
CA (1)	CA2247735A1 (fr)
CZ (1)	CZ303198A3 (fr)
DE (2)	DE19741873A1 (fr)
HR (1)	HRP980519A2 (fr)
HU (1)	HUP9802143A3 (fr)
ID (1)	ID20915A (fr)
IL (1)	IL126278A0 (fr)
MY (1)	MY134191A (fr)
NO (1)	NO984414L (fr)
NZ (1)	NZ331983A (fr)
PL (1)	PL191149B1 (fr)
RU (1)	RU2240326C2 (fr)
SK (1)	SK129598A3 (fr)
TR (1)	TR199801870A2 (fr)
TW (1)	TW588051B (fr)
ZA (1)	ZA988668B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19647380A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19741235A1 (de) *	1997-09-18	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19821483A1 (de)	1998-05-14	1999-11-18	Hoechst Marion Roussel De Gmbh	Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19922462A1 (de)	1999-05-17	2000-11-23	Aventis Pharma Gmbh	Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1244656A1 (fr)	1999-12-28	2002-10-02	Pfizer Products Inc.	Inhibiteurs non peptidyle de liaison cellulaire dependant de vla-4 utiles pour le traitement de maladies inflammatoires, auto-immunes et respiratoires
DE10111876A1 (de)	2001-03-10	2002-09-19	Aventis Pharma Gmbh	Bis(trifluormethyl)hydantoine als Zwischenprodukte für pharmazeutische Wirkstoffe
DE10111877A1 (de)	2001-03-10	2002-09-12	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de)	2001-08-01	2003-02-13	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
US7053112B2 (en) *	2002-09-24	2006-05-30	Schering Aktiengesellschaft	Imidazolidinedione analogs useful as anticoagulants and antithrombotics
KR20110117731A (ko)	2003-05-30	2011-10-27	랜박시 래보러터리스 리미티드	치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
US7577605B2 (en) *	2004-08-04	2009-08-18	Bgc Partners, Inc.	System and method for managing trading using alert messages for outlying trading orders
CA2627599A1 (fr)	2005-11-08	2007-05-18	Ranbaxy Laboratories Limited	Procede de preparation de sel hemicalcique d'acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
WO2011020874A1 (fr)	2009-08-20	2011-02-24	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Vla-4 en tant que biomarqueur pour le pronostic et le ciblage pour thérapie dans la dystrophie musculaire de duchenne
HUE050713T2 (hu)	2010-10-25	2020-12-28	Biogen Ma Inc	Módszerek az ALFA-4 integrin aktivitás eltéréseinek meghatározásához, a sVCAM ÉS/VAGY sMAdCAM szintek egymáshoz viszonyításával
JP2021066690A (ja) *	2019-10-24	2021-04-30	国立大学法人室蘭工業大学	オピオイドペプチド誘導体及びこれを含む医薬組成物
US20240301512A1 (en)	2021-01-29	2024-09-12	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE235866C (fr) *
DE3044236A1 (de) *	1980-11-25	1982-06-16	Hoechst Ag, 6000 Frankfurt	Aminosaeurederivate und verfahren zu ihrer herstellung
DE2937779A1 (de) *	1979-09-19	1981-04-09	Hoechst Ag, 6000 Frankfurt	Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) *	1979-12-07	1982-02-05	Science Union & Cie	Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2503155A2 (fr) *	1980-10-02	1982-10-08	Science Union & Cie	Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4350704A (en) *	1980-10-06	1982-09-21	Warner-Lambert Company	Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
EP0046953B1 (fr) *	1980-08-30	1989-12-06	Hoechst Aktiengesellschaft	Dérivés des acides aminés, leurs procédés de préparation, compositions les contenant et leur application
US4344949A (en) *	1980-10-03	1982-08-17	Warner-Lambert Company	Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
ATE20469T1 (de) *	1980-10-23	1986-07-15	Schering Corp	Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
US4374847A (en) *	1980-10-27	1983-02-22	Ciba-Geigy Corporation	1-Carboxyalkanoylindoline-2-carboxylic acids
DE3226768A1 (de) *	1981-11-05	1983-05-26	Hoechst Ag, 6230 Frankfurt	Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
CA1341296C (fr) *	1981-12-29	2001-09-25	Hansjorg Urbach	Derives d'acide 2-azabicycloalkene-3-carboxylique, leur procede de preparation, agents contenant ces composes et leur utilite
DE3210496A1 (de) *	1982-03-23	1983-10-06	Hoechst Ag	Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3211397A1 (de) *	1982-03-27	1983-11-10	Hoechst Ag, 6230 Frankfurt	Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3211676A1 (de) *	1982-03-30	1983-10-06	Hoechst Ag	Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
DE3227055A1 (de) *	1982-07-20	1984-01-26	Hoechst Ag, 6230 Frankfurt	Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
EP0109925A1 (fr) *	1982-09-30	1984-05-30	Ciba-Geigy Ag	Dérivés d'imidazolidine-2,4-dione doués d' activité microbicide
DE3242151A1 (de) *	1982-11-13	1984-05-17	Hoechst Ag, 6230 Frankfurt	Neue derivate tricyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung, sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3246503A1 (de) *	1982-12-16	1984-06-20	Hoechst Ag, 6230 Frankfurt	Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
DE3643012A1 (de) *	1986-12-17	1988-06-30	Hoechst Ag	2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3818850A1 (de) *	1988-06-03	1989-12-07	Hoechst Ag	Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DE4009506A1 (de) *	1990-03-24	1991-09-26	Hoechst Ag	Hydantoinderivate
DE4126277A1 (de) *	1991-08-08	1993-02-11	Cassella Ag	Hydantoinderivate
RU2032672C1 (ru) *	1991-08-20	1995-04-10	Институт физико-органической химии и углехимии им.Л.М.Литвиненко АН Украины	1,3-бис-(2,3-диакрилоилоксипропил) -5,5-диметил-2,4-имидазолидиндион в качестве модификатора фотополимеризующихся акрилатных композиций
DK0626861T4 (da) *	1992-01-13	2004-08-16	Biogen Inc	Behandling af astma.
JPH07506566A (ja) *	1992-02-12	1995-07-20	バイオゲン　インコーポレイテッド	炎症性胃腸病の処置
DE4207254A1 (de) *	1992-03-07	1993-09-09	Cassella Ag	4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) *	1992-04-24	1993-10-28	Cassella Ag	2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) *	1992-07-24	1994-01-27	Cassella Ag	Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4228717A1 (de) *	1992-08-28	1994-03-03	Cassella Ag	Imidazolidin-Derivate
SG52262A1 (en) *	1993-01-08	1998-09-28	Tanabe Seiyaku Co	Peptide inhibitors of cell adhesion
DK0678122T3 (da) *	1993-01-12	2000-03-06	Biogen Inc	Rekombinante anti-VLA4 antistofmolekyler
WO1994017828A2 (fr) *	1993-02-09	1994-08-18	Biogen, Inc.	Traitement du diabete insulino-dependant
DE4308034A1 (de) *	1993-03-13	1994-09-15	Cassella Ag	Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) *	1993-11-15	1996-02-15	Cassella Ag	Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
WO1995015973A1 (fr) *	1993-12-06	1995-06-15	Cytel Corporation	Peptidomimetiques cs-1, compositions et procedes pour les utiliser
EP0804237B8 (fr) *	1994-01-25	2006-11-08	Elan Pharmaceuticals, Inc.	Anticorps humanises diriges contre la molecule d'adhesion leucocytaire vla-4
WO1996000581A1 (fr) *	1994-06-29	1996-01-11	Texas Biotechnology Corporation	Procede permettant d'inhiber la fixation de l'integrine alpha 4 beta 1 a la molecule d'adherence cellulaire vasculaire 1 ou a la fibronectine
US5811391A (en) *	1994-08-25	1998-09-22	Cytel Corporation	Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en) *	1994-12-24	1996-01-31	Zeneca Ltd	Chemical compounds
US6306840B1 (en) *	1995-01-23	2001-10-23	Biogen, Inc.	Cell adhesion inhibitors
DE19515177A1 (de) *	1995-04-28	1996-10-31	Cassella Ag	Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
US5612363A (en) *	1995-06-02	1997-03-18	Berlex Laboratories, Inc.	N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US6248713B1 (en) *	1995-07-11	2001-06-19	Biogen, Inc.	Cell adhesion inhibitors
EP0796855B1 (fr) *	1996-03-20	2002-02-06	Hoechst Aktiengesellschaft	Inhibiteurs de la résorption osseuse et antagonistes du récepteur de la vitronectine
SG124234A1 (en) *	1996-07-25	2006-08-30	Biogen Idec Inc	Cell adhesion inhibitors
DE19647380A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647381A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
PL323130A1 (en) *	1996-11-15	1998-05-25	Hoechst Ag	Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
WO1998042656A1 (fr) *	1997-03-21	1998-10-01	Cytel Corporation	Nouveaux composes
DE19741235A1 (de) *	1997-09-18	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

1997
- 1997-09-23 DE DE19741873A patent/DE19741873A1/de not_active Withdrawn
1998
- 1998-09-17 EP EP98117660A patent/EP0905139B1/fr not_active Expired - Lifetime
- 1998-09-17 AT AT98117660T patent/ATE421524T1/de not_active IP Right Cessation
- 1998-09-17 DE DE59814334T patent/DE59814334D1/de not_active Expired - Lifetime
- 1998-09-17 IL IL12627898A patent/IL126278A0/xx not_active IP Right Cessation
- 1998-09-21 SK SK1295-98A patent/SK129598A3/sk unknown
- 1998-09-21 ID IDP981265A patent/ID20915A/id unknown
- 1998-09-21 NZ NZ331983A patent/NZ331983A/en unknown
- 1998-09-21 TR TR1998/01870A patent/TR199801870A2/xx unknown
- 1998-09-21 CA CA002247735A patent/CA2247735A1/fr not_active Abandoned
- 1998-09-21 CZ CZ983031A patent/CZ303198A3/cs unknown
- 1998-09-21 MY MYPI98004339A patent/MY134191A/en unknown
- 1998-09-22 RU RU98117626/04A patent/RU2240326C2/ru not_active IP Right Cessation
- 1998-09-22 AU AU86148/98A patent/AU748579B2/en not_active Ceased
- 1998-09-22 HR HR19741873.2A patent/HRP980519A2/hr not_active Application Discontinuation
- 1998-09-22 CN CN98119544A patent/CN1216767A/zh active Pending
- 1998-09-22 JP JP26835298A patent/JP4603104B2/ja not_active Expired - Fee Related
- 1998-09-22 ZA ZA988668A patent/ZA988668B/xx unknown
- 1998-09-22 BR BR9803969-5A patent/BR9803969A/pt not_active Application Discontinuation
- 1998-09-22 NO NO984414A patent/NO984414L/no not_active Application Discontinuation
- 1998-09-23 US US09/158,772 patent/US6034238A/en not_active Expired - Lifetime
- 1998-09-23 PL PL328789A patent/PL191149B1/pl unknown
- 1998-09-23 HU HU9802143A patent/HUP9802143A3/hu unknown
- 1998-09-23 KR KR1019980039351A patent/KR19990030046A/ko not_active Ceased
- 1998-09-25 TW TW087115671A patent/TW588051B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2247735A1 (fr)	1999-03-23
DE59814334D1 (de)	2009-03-12
EP0905139A2 (fr)	1999-03-31
EP0905139A3 (fr)	2002-12-18
HU9802143D0 (en)	1998-11-30
PL191149B1 (pl)	2006-03-31
EP0905139B1 (fr)	2009-01-21
BR9803969A (pt)	2000-05-02
HUP9802143A3 (en)	1999-11-29
MY134191A (en)	2007-11-30
SK129598A3 (en)	1999-04-13
RU2240326C2 (ru)	2004-11-20
IL126278A0 (en)	1999-05-09
AU748579B2 (en)	2002-06-06
ATE421524T1 (de)	2009-02-15
DE19741873A1 (de)	1999-03-25
NO984414D0 (no)	1998-09-22
NZ331983A (en)	2000-02-28
AU8614898A (en)	1999-04-15
HRP980519A2 (en)	1999-06-30
CZ303198A3 (cs)	1999-04-14
TR199801870A2 (xx)	1999-04-21
KR19990030046A (ko)	1999-04-26
TW588051B (en)	2004-05-21
PL328789A1 (en)	1999-03-29
ID20915A (id)	1999-03-25
ZA988668B (en)	1999-03-23
CN1216767A (zh)	1999-05-19
US6034238A (en)	2000-03-07
JP4603104B2 (ja)	2010-12-22
HUP9802143A2 (hu)	1999-06-28
JPH11180960A (ja)	1999-07-06

Legal Events

Date	Code	Title	Description
2007-01-15	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO984414D0 (no)	1998-09-22	Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse
TW342310B (en)	1998-10-11	Non-systemic external dermal control of parasites
NO890813L (no)	1989-08-30	5-lipoxygenase-inhiberende 4-(4-fenyl-1-piperazinyl)fenoler.
DK0681581T3 (da)	1998-05-04	Substituerede, kondenserede, pyrazolforbindelser og deres anvendelse som herbicider.
BR0017010A (pt)	2002-11-05	Agentes antibacterianos 3-aminoquinazolin-2,4-diona
WO2001032654A3 (fr)	2001-09-27	Nouveaux composes heterocycliques et leur application a titre de medicaments
DK51986A (da)	1986-08-05	Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
DK0593639T3 (da)	1995-07-03	Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse
NO924696L (no)	1992-12-04	Fremgangsmaate for fremstilling av oksazolidinon- og tiazolidinon-derivater
NO20051695L (no)	2005-04-05	Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO940524D0 (no)	1994-02-15	Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser
DK591488A (da)	1989-04-27	1-acyl-3-oe4-(2-pyrimidinyl)-1-piperazinylaapropan-forbindelser, deres anvendelse til fremstilling af et angstdaempende laegemiddel og farmaceutiske praeparater indeholdende disse forbindelser
NO20004273L (no)	2000-10-23	Streptograminderivater, deres fremstilling samt preparater inneholdende forbindelsene
BR0016517A (pt)	2002-09-17	Derivados diacila de diamina de propileno herbicidas
DK266686A (da)	1986-12-08	1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer
DK34087D0 (da)	1987-01-22	Acyltripeptid-forbindelser og deres anvendelse som immunostimulanter
NO954892L (no)	1995-12-01	Heterosyklisk kjemi
ATE189894T1 (de)	2000-03-15	Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DK369289A (da)	1990-01-27	Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
NO931679D0 (no)	1993-05-07	Nye heterocykliske forbindelser som antagonister for eksitatoriske aminosyrereseptorer, fremgangsmaater for deres fremstilling og deres anvendelse
EP0313311A3 (fr)	1990-03-07	Sulfonamides herbicides
NO174388C (no)	1994-04-27	Nitrogenholdige, heterocykliske forbindelser og anti-funguspreparate
HUT42278A (en)	1987-07-28	Herbicidal compositions comprising 5-sulfamino-1-aryl-pyranol derivatives as active substance and process for preparing the active substances
EP0878475A3 (fr)	1998-11-25	Dérivés de 5-(4-pipéridinyl)dibenzothiazépine et de 5-(4-pipéridinyl)dibenzoxazépine et agents antiarhythmiques
BR9816018A (pt)	2001-06-05	Derivados de carbolina como inibidores de fosfodiesterase de cgmp